Clinical Trial Update: Effect of Testosterone Replacement on Insulin Resistance [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of testosterone replacement on insulin resistance in individuals with metabolic syndrome and hypogonadism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Metabolic Syndrome

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: McGuire Research Institute | Conditions: Metabolic Syndrome, Hypogonadism | Phase 4 | Status: COMPLETED